Biological Performance of Materials: Fundamentals of Biocompatibility, Fourth Edition

Biological Performance of Materials: Fundamentals of Biocompatibility, Fourth Edition

Volumn , Issue , 2005, Pages 1-497

  Black, Jonathan ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85128634372     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (263)

1. Black, J, Shalaby, SW, LaBerge, M. Biomaterials education: an academic viewpoint. J. Appl. Biomater., 3, 231, 1992.
2. Moss, AJ, et al., Use of selected medical device implants in the United States, 1988, Advance Data No. 191, February 26, 1991, Centers for Disease Control, National Center for Health Statistics, Washington, D.C.
3. Osborn, JF, Biomaterials and their use in implants, Schw. Mschr. Zahnheilk., 89, 1138, 1979.
4. Slutskii, LI, Vetra, JJ, Letter to the editor: biocompatibility and reactogenicity of materials: a semantic and logical analysis of definitions and their practical significance, Cells Mater., 6, 137, 1996.
5. Warnke, PH, et al., Growth and transplantation of a custom vascularised bone graft in a man, Lancet, 364, 766, 2004.
6. Williams, DF, (Ed.), Definitions in Biomaterials: Proceedings of a Consensus Conference of the European Society for Biomaterials, Chester, England, March 3-5, 1986. Elsevier, Amsterdam, 1987
7. Black, J., Prospects for alternate bearing surfaces in total replacement arthroplasty of the hip, in Performance of the Wear-Couple BIOLOX Forte in Hip Arthroplasty, Puhl, W. (Ed.), Enke Verlag, Stuttgart, 1997, 2.
8. Black, J. and Hastings, G.W. (Eds.), Handbook of Biomaterial Properties, Part 1, Chapman & Hall, London, 1998.
9. Chau, T.T. et al., Microwave plasmas for low-temperature dry sterilization, Biomaterials, 17, 1273, 1996.
10. Chen, E.H. and Black, J., Materials design analysis of the prosthetic anterior cruciate ligament, J. Biomed. Mater. Res., 14, 567, 1980.
11. Dane, S. et al., Differences between right- and left-femoral bone mineral densities in right- and left-handed men and women, Int. J. Neurosci., 111(3-4), 187, 2001.
12. Edidin, A.A. et al., Accelerated aging studies of UHMWPE. I. Effect of resin, processing, and radiation environment on resistance to mechanical degradation, J.Biomed. Mater. Res., 61(2), 312, 2002.
13. Nuutinen, J.P. et al., Effect of gamma, ethylene oxide, electron beam, and plasma sterilization on the behavior of SR-PLLA fibers in vitro, J. Biomater. Sci. Polym. Ed., 13(12), 1325, 2002.
14. Schmalzried, T.P. et al., Wear is a function of use, not time, Clin. Orthop. Rel. Res., 381, 36, 2000.
15. Stanford, C.M., Keller, J.C. and Solursh, M., Bone cell expression on titanium surfaces is altered by sterilization treatments, J. Dent. Res., 73(5), 1061, 1994.
16. Carmen, R. and Kahn, P., In vitro testing of silicone rubber heart-valve poppets for lipid absorption, J. Biomed. Mater. Res., 2, 457, 1968.
17. Chien, Y.W., Rate-control drug delivery systems: controlled release vs. sustained release, Med. Prog. Technol., 15, 21, 1989.
18. McHenry, M.M. et al., Critical obstruction of prosthetic heart valves due to lipid absorption by Silastic, J. Thorac. Cardiovasc. Surg., 59, 413, 1970.
19. Mitragotri, S. et al., A mechanistic study of ultrasonically enhanced transdermal drug delivery, J. Pharmaceutical Sci., 84(6), 697, 1995.
20. Pfleiderer, B. et al., Study of aging of silicone rubber biomaterials with NMR, J. Biomed. Mater. Res., 29, 1129, 1995.
21. Refojo, M.F., Vapor pressure and swelling pressure of hydrogels, in Hydrogels for Medical and Related Applications, Andrade, J.D. (Ed.), American Chemical Society, Washington, D.C., 1976, 37.
22. Singh, P. and Maibach, H.I., Transdermal iontophoresis. Pharmacological considerations, Clin. Pharmacol., 26(5), 327, 1994.
23. Swanson, A.B. et al., Durability of silicone implants - an in vivo study, Orthop. Clin. N. Am., 4(4), 1097, 1973.
24. Blackwood, D.J. and Pereira, B.P., No corrosion of 304 stainless steel implant after 40 years of service, J. Mater. Sci.: Mater. Med., 15, 755, 2004.
25. Brown, S.A. and Merritt, K., Fretting corrosion in saline and serum, J. Biomed. Mater. Res., 15, 479, 1981.
26. Browne, M. and Gregson, P.J., Surface modification of titanium alloy implants, Biomaterials, 15, 894, 1994.
27. Bundy, K.J., Williams, C.J. and Luedemann, R.E., Stress-enhanced ion release - the effect of static loading, Biomaterials, 12, 627, 1991.
28. Callen, B.W. et al., Nitric acid passivation of Ti6Al4V reduces thickness of surface oxide layer and increases trace element release, J. Biomed. Mater. Res., 29, 279, 1995.
29. Cohen, J. and Lindenbaum, B., Fretting corrosion in orthopedic implants, Clin. Orthop. Rel. Res., 61, 167, 1968.
30. Colangelo, V.J. and Greene, N.D., Corrosion and fracture of type 316 SMO orthopedic implants, J. Biomed. Mater. Res., 3, 247, 1969.
31. Cook, S.D. et al., Clinical and metallurgical analysis of retrieved internal fixation devices, Clin. Orthop. Rel. Res., 194, 236, 1985.
32. Rogers, G.T., In vivo production of hexavalent chromium, Biomaterials, 5, 244, 1984.
33. Steinemann, S.G., Corrosion of surgical implants - in vivo and in vitro tests, in Evaluation of Biomaterials, Winter, G.D., Leray, J.L. and deGroot, K. (Eds.), John Wiley & Sons, Chichester, U.K., 1980, 1.
34. Sutow, E.J., Pollack, S.R. and Korostoff, E., An in vitro investigation of the anodic polarization and capacitance behavior of 316-L stainless steel, J. Biomed. Mater. Res., 10, 671, 1976.
35. Svare, C.W., Belton, G. and Korostoff, E., The role of organics in metallic passivation, J. Biomed. Mater. Res., 4, 457, 1970.
36. Thomas, C.J., Edyvean, R.G.J. and Brook, R., Biologically enhanced corrosion fatigue, Biofouling, 1, 65, 1988.
37. Wilson, M. et al., Corrosion of intraoral magnets by multi-species biofilms in the presence and absence of sucrose, Biomaterials, 18, 53, 1997.
38. Yang, J. et al., Human neutrophil response to short-term exposure to F-75 cobalt-base alloy, J. Biomed. Mater. Res., 26, 1217, 1992.
39. Andrade, J.D., Interfacial phenomena and biomaterials, Medical Instrumen. 7, 110, 1973.
40. Baszkin, A. and Lyman, D.J., The interaction of plasma proteins with polymers. I. Relationship between polymer surface energy and protein adsorption/desorption, J. Biomed. Mater. Res., 14, 393, 1980.
41. Stern, I.J. et al., Immunogenic effects of foreign materials on plasma proteins, Nature, 238, 151, 1972.
42. West, J.K., Latour, R., Jr. and Hench, L.L., Molecular modeling study of the adsorption of poly-L-lysine onto silica glass, J. Biomed. Mater Res., 37, 585, 1997.
43. Williams, R.L. and Williams, D.F., Albumin adsorption on metal surfaces, Biomaterials, 9, 206, 1988.
44. Woodman, J.L., Black, J. and Jiminez, S.A., Isolation of serum protein organometallic corrosion products from 316LSS and HS-21 in vitro and in vivo, J. Biomed. Mater. Res., 18, 99, 1984.
45. Adams, R. and McMillan, P.W., Review: static fatigue in glass, J. Mater. Sci., 12, 643, 1977.
46. Allara, D.L., Aging of polymers, Environ. Health Perspec., 11, 29, 1975.
47. Chu, C.C., The effect of pH on the in vitro degradation of poly(glycolide lactide) copolymer absorbable sutures, J. Biomed. Mater. Res., 16, 117, 1982.
48. Dumbleton, J.H. and Black, J., An Introduction to Orthopedic Materials, Charles C Thomas, Springfield, IL, 1975.
49. Postlethwait, R.W., Long-term comparative study of nonabsorbable sutures, Ann. Surg., 171, 892, 1970.
50. Rose, R.M., et al., The role of stress-enhanced reactivity in failure of orthopaedic implants, J. Biomed. Mater. Res. Symp., 4, 401, 1973.
51. Salthouse, T.N., Williams, J.A. and Willigan, D.A., Relationship of cellular enzyme activity to catgut and collagen suture absorption, Surg., Gyn. Obstet., 129, 691, 1969.
52. Sauer, W.L., Weaver, K.D. and Beals, N.B., Fatigue performance of ultra-high-molecular-weight polyethylene: effect of gamma radiation sterilization, Biomaterials, 17, 1929, 1996.
53. Takahashi, K., Cracking of poly(methyl methacrylate) caused by plane stress waves, J. Macromol. Sci. Phys., B8(3-4), 673, 1973.
54. Bartel, D.L. et al., The effect of conformity and plastic thickness on contact stresses in metal-backed plastic implants, J. Biomech. Eng., 107, 193, 1985.
55. Dintenfass, L., Lubrication in synovial joints: a theoretical analysis, J. Bone Joint Surg., 45A, 1241, 1963.
56. Dörre, E., Beutler, H. and Geduldig, D., The properties required of bioceramics for artificial joints (author's transl.), Arch. Orthop. Unfall.-Chir., 83, 269, 1975.
57. Dowling, J.M. et al., The characteristics of acetabular cups worn in the human body, J. Bone Joint Surg., 60B, 375, 1978.
58. Hills, B.A. and Butler, B.D., Surfactants identified in synovial fluid and their ability to act as boundary lubricants, Ann. Rheu. Dis., 43, 641, 1984.
59. Jablonski, J.E., Stone, J. and Black, J., The effect of articulation on the corrosion potential of cobalt-chromium alloy in vitro, Trans. SFB, 9, 196, 1986.
60. Wang, A., Essner, A. and Schmidig, G., The effects of lubricant composition on in vitro wear testing of polymeric acetabular components, J. Biomed. Mater. Res. Part B: Appl. Biomater., 68B, 45, 2004.
61. Weightman, B. et al., Lubrication mechanism of hip joint replacement prostheses, J. Lubric. Tech., 94, 131, 1972.
62. Woodman, J.L. et al., Isolation of lubricating fraction from human synovial fluid after total-hip implantation, Trans. ORS, 2, 13, 1977.
63. Wright, V. (Ed.), Lubrication and Wear in Joints, J.B. Lippincott Company, Philadelphia, 1969.
64. Ahmed, T. et al., A new low-modulus, biocompatibile titanium alloy, Proc. Inst. Metal. 8th World Titanium Conf., 1996, 742.
65. Boretos, J.W. and Pierce, W.S., Segmented polyurethane: a polyether polymer, J. Biomed. Mater. Res., 2, 121, 1968.
66. Borowy, K.-H. and Kramer, K.-H., On the properties of a new titanium alloy (TiAl5Fe2.5) as implant material, in Titanium Science and Technology, Vol. 2, Luterjering, G., Zwicker, U. and Bunk, W. (Eds.), Deutsche Gesell. f. Metallkunde e. V., Obureresel, 1985, 1381.
67. Braley, S., The chemistry and properties of the medical-grade silicones, J. Macromol. Sci.-Chem., A4(3), 529, 1970.
68. Brückmann, H. and Hüttinger, K.J., Carbon, a promising material in endoprosthetics. Part 1: the carbon materials and their mechanical properties, Biomaterials, 1, 67, 1980.
69. Hastings, G.W., Carbon fiber composites for orthopedic implants, Composites, 7, 193, 1978.
70. Hench, L.L. and Wilson, J., Surface-active biomaterials, Science, 226, 630, 1984.
71. Kurtz, S.M., The UHMWPE Handbook: Ultra-High Molecular Weight Polyethylene in Total Joint Replacement, Academic Press (Elsevier), New York, 2004.
72. Roe, R.-J. et al., Effect of radiation sterilization and aging on ultrahigh molecular weight polyethylene, J. Biomed. Mater. Res., 15, 209, 1981.
73. Schwartz, M.M., Composite Materials Handbook, McGraw-Hill, New York, 1984.
74. Zimmer, Nonauthored technical material, Warsaw, IN, 1978.
75. Albrektsson, T. et al., The interface zone of inorganic implants in vivo: titanium implants in bone, Ann. Biomed. Eng., 11, 1, 1983.
76. Anderson, J.M. and Miller, K.M., Biomaterial biocompatibility and the macrophage, Biomaterials, 5, 5, 1984.
77. Antti-Poika, I. et al., Hip arthroplasty infection, Acta Orthop. Scand., 61, 163, 1990.
78. Mariano, M. and Spector, W.G., The formation and properties of macrophage polykaryons (inflammatory giant cells), J. Pathol., 113, 1, 1974.
79. Masui, T., Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt-chromium and polyethylene particles, Biomaterials, 26, 1695, 2005.
80. McNamara, A. and Williams, D.F., Scanning electron microscopy of the metal-tissue interface. I. Fixation methods and interpretation of results, Biomaterials, 3, 160, 1982.
81. Merritt, K., Shafer, J.W. and Brown, S.A., Implant site infection rates with porous and dense materials, J. Biomed. Mater. Res., 13, 101, 1979.
82. Petty, W. et al., The influence of skeletal implants on incidence of infection, J. Bone Joint Surg., 67A, 1236, 1985.
83. Petty, W., Spanier, S. and Shuster, J.J., Prevention of infection after total joint replacement, J. Bone Joint Surg., 70A, 536, 1988.
84. Rae, T., A study on the effects of particulate metals of orthopedic interest on murine macrophages in vitro, J. Bone Joint Surg., 57B, 444, 1975.
85. Willert, H.-G. and Semlitsch, M., Reactions of the articular capsule to wear products of artificial joint prostheses, J. Biomed. Mater. Res., 11, 157, 1977.
86. Wood, N.K., Kaminski, E.J. and Oglesby, R.J., The significance of implant shape in experimental testing of biological materials: disc vs. rod, J. Biomed. Mater. Res., 4, 1, 1970.
87. Younger, A.S. et al., The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip, J. Arthoplasty, 12(6), 615, 1997.
88. Ziats, N.P., Miller, K.M. and Anderson, J.M., In vitro and in vivo interactions of cells with biomaterials, Biomaterials, 9, 5, 1988.
89. Baier, R.E., The role of surface energy in thrombogenesis, Bull. N.Y. Acad. Med., 48, 257, 1972.
90. Anerjee, R. et al., Hematological aspects of biocompatibility - review article, J.Biomater. Appl., 12, 57, 1997.
91. Nosé, Y. et al., Surface characteristics of cardiac prostheses in vivo, J. Biomed. Mater. Res. Symp., 8, 85, 1977.
92. Salzman, E.W., Surface effects in hemostasis and thrombosis, in The Chemistry of Biosurfaces, Vol. II. Hair, M.L. (Ed.), Marcel Dekker, New York, 1972, 489.
93. Skarja, G.A. et al., A cone-and-plate device for the investigation of platelet biomaterial interactions, J. Biomed. Mater. Res., 34, 427, 1997.
94. Vogler, E.A., Structure and reactivity of water at biomaterial surfaces, Adv. Colloid Interface Sci., 74, 69, 1998.
95. Vroman, L., Summation: protein at the interface, Fed. Proc., 30, 1703, 1971.
96. Weinberg, C.B. and Bell, E., A blood vessel model constructed from collagen and cultured vascular cells, Science, 231, 397, 1986.
97. Albrektsson, T. and Hansson, H.-A., An ultrastructural characterization of the interface between bone and sputtered titanium or stainless steel surfaces, Biomaterials, 7, 201, 1986.
98. Alexander, H. et al., Ligament and tendon replacement with resorbable polymerfilamentous carbon tissue scaffolds, Trans. Orthop. Res. Soc., 4, 27, 1979.
99. Amstutz, H.C. et al., Mechanism and clinical significance of wear debris-induced osteolysis. Clin. Orthop. Rel. Res., 276, 7, 1992.
100. Annis, D. et al., An elastomeric vascular prosthesis, Trans. Am. Soc. Artif. Intern. Organs, XXIV, 209, 1978.
101. Balduini, F.C., Clemow, A.J.T. and Lehman, R.C., Synthetic Ligaments: Scaffolds, Stents, and Prostheses, Slack, Thorofare, NJ, 1986.
102. Jenkins, D.H.R. et al., Induction of tendon and ligament formation by carbon implants, J. Bone Joint Surg., 59B, 53, 1977.
103. Kahn, R.H. and Burkel, W.E., Propagation of pseudointimal linings of vascular prostheses, In Vitro, 8, 451, 1973.
104. Klawitter, J.J. and Hulbert, S.F., Application of porous ceramics for the attachment of load-bearing internal orthopedic applications, J. Biomed. Mater. Res. Symp., 2, 161, 1971.
105. Klawitter, J.J. and Weinstein, A.M., The status of porous materials to obtain direct skeletal attachment by tissue ingrowth, Acta Orthop. Belgica, 40, 755. 1974.
106. Linder, L., Osseintegration of metallic implants. I. Light microcopy in the rabbit, Acta Orthop. Scand., 60, 129, 1989.
107. Schoen, F.J., Interventional and Surgical Cardiovascular Pathology: Clinical Correlations and Basic Principles, W.B. Saunders, Philadelphia, 1989, 36.
108. Spector, M., Reply to comments on "characteristics of tissue growth into Proplast and porous polyethylene implants in bone," J. Biomed. Mater. Res., 13, 991, 1979.
109. Spector, M., Harmon, S.L. and Kreutner, A., Characteristics of tissue growth into proplast and porous polyethylene implants in bone, J. Biomed. Mater. Res., 13, 677, 1979.
110. Wesolowski, S.A. et al., Arterial prosthetic materials, Ann. N.Y. Acad. Sci., 146(1), 325, 1968.
111. Wolff, J., Das Gesetz der Transformation der Knochen, A. Hirschwald, Berlin, 1892.
112. Alexander, K.L. and Baker, S., Governor Casey's timely transplant, Bus. Week, June 28, 1993.
113. Anderson, J.P. et al., Structural evolution of genetically engineered silk like protein polymers, in Silk Polymers: Materials Science and Biotechnology (ACS Symposium Series #544). Kaplan, D., Adams, W.W., Farmer, B. and Viney, C. (Eds.), American Chemical Society, Washington, D.C., 1994, p. 137.
114. Barnard, C.N., The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town, S. Afr. Med. J., 41(48), 1271, 1967.
115. Bell, E., Strategy for the selection of scaffolds for tissue engineering, Tissue Eng., 1(2), 163, 1995.
116. Black, J., Tissue properties: relationship of in vitro studies to in vivo behavior, in Natural and Living Biomaterials, Hastings, G.W. and Ducheyne, P. (Eds.), CRC Press, Boca Raton, FL, 1984, 5.
117. Black, J., Thinking twice about tissue engineering, IEEE Eng. Biol. Med., 16(4), 102, 1997.
118. Brittberg, M. et al., Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation, New Engl. J. Med., 331(14), 889, 1994.
119. Campbell, K.H. et al., Implications of cloning, Nature, 6573, 383, 1996.
120. Uniform Anatomical Gift Act (1968, as amended 1987), National Conference of Commissioners on Uniform State Laws, C. 1:12A-8 (subsequently adopted by individual states (U.S.)).
121. Vacanti, J.P. and Vacanti, C.A., History and scope of tissue engineering, in Lanza, R.P., Langer, R. and Chick, W.L. (Eds.), Principles of Tissue Engineering, 2nd ed., Elsevier Science, New York, 2000, 3.
122. Yannas, I.V. and Burke, J.F., Design of an artificial skin. I. Basic design principles, J. Biomed. Mater. Res., 14, 65, 1980.
123. Yannas, I.V., In vivo synthesis of tissues and organs, in Lanza, R.P., Langer, R. and Chick, W.L. (Eds.), Principles of Tissue Engineering, 1st ed., Elsevier Science, New York, 1997, 167.
124. Angel, M., Science on Trial, W.W. Norton and Co., New York, 1997.
125. Bajpai, P.K., Antigenicity of glutaraldehyde-stabilized biological materials, in Biomaterials in Reconstructive Surgery, Rubin, L.R. (Ed.), C.V. Mosby, St. Louis, 1983, 243.
126. Benson, M.K.D. et al., Metal sensitivity in patients with joint replacement arthroplasties, Br. Med. J., 4, 374, 1975.
127. Bravo, I. et al., Differential effects of eight metal ions on lymphocyte differentiation antigens in vitro, J. Biomed. Mater. Res., 24, 1059, 1990.
128. Brendlinger, D.L. and Tarsitano, J.J., Generalized dermatitis due to sensitivity to a chrome cobalt removable partial denture, J. Am. Dent. Assoc., 81, 392, 1970.
129. Brown, G.C. et al., Sensitivity to metal as a possible cause of sterile loosening after cobalt-chromium total hip-replacement arthroplasty, J. Bone Joint Surg., 59A, 164, 1977.
130. Carlsson, A.S. et al., Metal sensitivity in patients with metal-to-plastic total hip arthroplasties, Acta Orthop. Scand., 51, 57, 1980.
131. Chenoweth, D.E., Complement activation produced by biomaterials, Trans. Am. Soc. Artif. Intern. Organs, 32, 226, 1986.
132. Chenoweth, D.E., Complement activation in extracorporeal circuits, Ann. N.Y. Acad. Sci., 516, 306, 1987.
133. Clementi, D. et al., Clinical investigations of tolerance to materials and acrylic cement in patients with hip prostheses, Ital. J. Orthop. Traumatol., 6, 97, 1980.
134. Cramers, M. and Lucht, U., Metal sensitivity in patients treated for tibial fractures with plates of stainless steel, Acta Orthop. Scand., 48, 245, 1977
135. Wahlberg, J.E., Thresholds of sensitivity in metal contact allergy. 1. Isolated and simultaneous allergy to chromium, cobalt, mercury, and/or nickel, Berufsdermatosen, 21, 22, 1973.
136. Waterman, A.H. and Schrik, J.J., Allergy in hip arthroplasty, Contact Derm., 13, 294, 1985.
137. Willert, H.-G. and Semlitsch, M., Reactions of the articular capsule to wear products of artificial joint prostheses, J. Biomed. Mater. Res., 11, 157, 1977.
138. Wooley, P.H. et al., Cellular immune responses to orthopedic implant materials following cemented total joint replacement, J. Orthop. Res., 15, 874, 1997.
139. Yang, J. and Merritt, K., Detection of antibodies against corrosion products in patients after Co-Cr total joint replacements, J. Biomed. Mater. Res., 28, 1249, 1994.
140. Yang, J. and Merritt, K., Production of monoclonal antibodies to study corrosion products of Co-Cr biomaterials, J. Biomed. Mater. Res., 31, 71, 1996.
141. Adams, J.E. et al., Prosthetic implant associated sarcomas: a case report emphasizing surface evaluation and spectroscopic trace meta analysis, Ann. Diagn. Pathol., 7(1), 35, 2003.
142. Alexander, P. and Horning, E.S., Observations on the Oppenheimer method of inducing tumors by subcutaneous implantation of plastic films, in Carcinogenesis: Mechanisms of Action, Ciba Foundation Symposium, Wolstenholme, G.E.W. and O'Connor, M. (Eds.), Little, Brown, Boston, 1959, 12.
143. American Cancer Society, 2004 Cancer Facts and Figures, American Cancer Society, Atlanta, 2004.
144. Ames, B.N. and Gold, L.S., Too many rodent carcinogens: mitogenesis increases mutagenesis, Science, 249, 970, 1990.
145. Harrison, J.W. et al., Osteosarcoma associated with metallic implants, Clin. Orthop. Rel. Res., 116, 253, 1976.
146. Heath, J.C. et al., Carcinogenic properties of wear particles from prostheses made in cobalt-chromium alloy, Lancet (March 20), 564, 1971.
147. Heselson, N.G. et al., Two malignant fibrous histiocytomas in bone infracts, J. Bone Joint Surg., 65A, 1166, 1983.
148. IARC, Surgical implants and other foreign bodies, IARC Monogr. Evaluation Carcinogenic Risks Hum., Vol. 74, WHO, IARC, Lyon, France, 1999.
149. Innes, J.R.M. et al., Bioassay of pesticides and industrial chemicals for tumorgenicity in mice: a preliminary note, J. Natl. Cancer Inst., 42, 1101, 1969.
150. Isomaki, H.A. et al., Excess risk of lymphomas, leukemia, and myeloma in patients with rheumatoid arthritis, J. Chron. Dis., 31, 691, 1978.
151. U.S. Department of Health and Human Services, Report on Carcinogens, 11th ed., U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, December 2004.
152. Vahey, J.W. et al., Carcinogenicity and metal implants, Am. J. Orthop., 24(4), 319, 1995.
153. Visuri, T. and Koskenvuo, M., Cancer risk after Mckee-Farrar total hip replacement, Orthopedics, 14(2), 137, 1991.
154. Weisburger, J.H. and Williams, G.M., Metabolism of chemical carcinogens, in Cancer: A Comprehensive Treatise, Vol. 1, Becker, F.F. (Ed.), Plenum Press, New York, 1975, 185.
155. Bacon, B.R., Metabolic liver disease. Iron overload states, Clin. Liver Dis., 2(1), 63, 1998.
156. Baran, E.J., Trace elements supplementation: recent advances and perspectives, Mini Rev. Med. Chem., 4(1), 1, 2004.
157. Caussy, D. et al., Lessons from case studies of metals: investigating exposure, bioavailability, and risk, Ecotox. Environ. Safety, 56, 45, 2003.
158. Dayan, A.D. and Paine, A.J., Mechanisms of chromium toxicity, carcinogenicity, and allergenicity: review of the literature from 1985 to 2000, Hum. Exp. Toxic., 20, 439, 2001.
159. Fairbanks, V.F. and Beutler, E., Iron, in Modern Nutrition in Health and Disease, 7th ed., Shils, M.E. and Young, V.R. (Eds.), Lea & Febiger, Philadelphia, 1988, 193.
160. Gitlow, S.E. and Beyers, M.R., Metabolism of iron, J. Lab. Clin. Med., 39, 337, 1952.
161. Kruse-Jarres, J.D., Clinical indications for trace element analysis, J. Trace Elem. Electrolytes Health Dis., 1, 5, 1987.
162. Langard, S. and Norseth, T., Chromium, in Handbook on the Toxicology of Metals, 2nd ed. Vol. II: Specific Metals, Friberg, L., Nordberg, G.F. and Vouk, V.B. (Eds.), Elsevier, Amsterdam, 1986, 185.
163. Vincent, J.B., Recent developments in the biochemistry of chromium (III), Biolog. Trace Elem. Res., 99, 1, 2004.
164. Walter, T. et al., Iron, anemia, and infection, Nutr. Rev., 55(4), 111, 1997.
165. Ward, C.G., Bullen, J.J. and Rogers, H.J., Iron and infection: new developments and their implications, J. Trauma, 41(2), 356, 1996.
166. Weinberg, E.D., Roles of iron in host-parasite interactions, J. Infect. Dis., 124, 401, 1971.
167. Weinberg, E.D., Iron and susceptibility to infectious disease, Science, 184, 952, 1974.
168. Weinberg, E.D. Iron withholding: a defense against viral infections, Biometals, 9(4), 393, 1996.
169. Winter, G.D., Wear and corrosion products in tissues and the reactions they provoke, in Biocompatibility of Implant Materials, Williams, D. (Ed.), Sector Publications, London, 1976, 28.
170. Aalders, G.J. et al., An exceptional case of pneumothorax - "a new adventure of the K wire," Injury, 16, 564, 1985.
171. Albores-Saavedra, J. et al., Sinus histiocytosis of pelvic lymph nodes after hip replacement. A histiocytic proliferation induced by cobalt-chromium and titanium, Am. J. Surg. Pathol., 18, 83, 1994.
172. Araki, S. et al., Filterable plasma concentration, glomerular filtration, tubular balance, and renal clearance of heavy metals and organic substances in metal workers, Arch. Environ. Health, 41, 216, 1986a.
173. Ferguson, A.B. et al., Trace metal ion concentration in the liver, kidney, spleen, and lung of normal rabbits, J. Bone Joint Surg., 44A, 317, 1962a.
174. Ferguson, A.B. et al., Characteristics of trace ions released from embedded metal implants in the rabbit, J. Bone Joint Surg., 44A, 323, 1962b.
175. Ganong, W.F., Renal function and micturation, in Review of Medical Physiology, 14th ed., Appleton & Lange, Norwalk, CT, 1989, 593.
176. Gatti, A.M. and Rivasi, F., Biocompatibility of micro- and nanoparticles. Part I: in liver and kidney, Biomaterials 23(11), 2381, 2002.
177. Graham, J.A. et al., Effect of trace metals on phagocytosis by alveolar macrophages, Infect. Immunol., 11, 1278, 1975.
178. Smith, G.K. and Black, J., Elevation of Fe and Cr concentrations in blood plasma after stainless steel implantation, Trans. ORS, 2, 281, 1977.
179. Stensaas, S.S. and Stensaas, L.J., Histopathological evaluation of materials implanted in the cerebral cortex, Acta. Neuropath. (Berl.), 41, 145, 1978.
180. Stiffel, C. et al., Kinetics of the phagocytic function of reticuloendothelial macrophages in vivo, in Mononuclear Macrophages, van Furth, R. (Ed.), Academic Press, New York, 1970, 335.
181. Styles, J.A. and Wilson, J., Comparison between in vitro toxicity of two novel fibrous mineral dusts and their tissue reactions in vivo, Ann. Occup. Hyg., 19, 63, 1976.
182. Sunderman, F.W., Jr. et al., Cobalt, chromium, and nickel concentrations in body fluids of patients with porous-coated knee or hip prostheses, J. Orthop. Res., 7, 307, 1989.
183. Weisman, R.A. and Korn, E.D., Phagocytosis of latex beads by acanthamoeba I. Biochemical properties, Biochemistry, 6, 485, 1967.
184. Woodman, J.L. et al., Release of cobalt and nickel from a new total finger joint prosthesis made of vitallium, J. Biomed. Mater. Res., 17, 655, 1983.
185. Baranowski, T.J., Jr. and Black, J., The mechanism of faradic stimulation of osteogenesis, in Mechanistic Approaches to Interactions of Electric and Electromagnetic Fields with Living Systems, Blank, M. and Findl, E. (Eds.), Plenum Press, New York, 1987, 399.
186. Black, J., Orthopedic Biomaterials in Research and Practice, Churchill-Livingstone, New York, 1988, 319.
187. Black, J., "And there are no data, he said," Biomater. Forum, 12(4), 9, 1990.
188. Black, J., Overview of PMS in an international perspective: global developments and global cooperation, Int. J. Risk Safety Med., 8, 3, 1996.
189. Boretos, J.W., Concise Guide to Biomedical Polymers: Their Design, Fabrication, and Molding, Charles C Thomas, Springfield, IL, 10, 1973.
190. Boretos, J.W. and Pierce, W.S., Segmented polyurethane: a polyether polymer, J. Biomed. Mater. Res., 2, 121, 1968.
191. Duncan, E., Editorial: endangered species? Biomater. Forum, 12(3), 4, 1990.
192. Jacobs, J.J. et al., Release and excretion of metal in patients who have a total hipreplacement component made of titanium-base alloy, J. Bone Joint Surg., 73A, 1475, 1991.
193. Moss, A.J. et al., Advance Data No. 191, (PHS) 91-1250. U.S. Government Printing Office, Washington, D.C., 1991.
194. Stokes, K.B. and Chem, B., Polyether polyurethanes, biostable or not? J. Biomater. Appl., 3, 228, 1988.
195. Stoppert, J.R. (1989), Letter cited in Duncan, E., Biomater. Forum, 12(3), 4, 1990.
196. Zhao, Q. et al., Cellular interactions with biomaterials: in vivo cracking of prestressed Pellethane 2363-80A, J. Biomed. Mater. Res., 24, 621, 1990.
197. Ames, B.N., Identifying environmental chemicals causing mutations and cancer, Science, 204, 587, 1979.
198. Ames, B.N., McCann, J. and Yamasaki, E., Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test, Mutat. Res., 31, 347, 1975.
199. Ashby, J. and Styles, J.A., Does carcinogenicity potency correlate with mutagenic potency in the Ames assay? Nature, 271, 452, 1978.
200. Autian, J., Toxicological evaluation of biomaterials: primary acute toxicity screening program, Artif. Organs, 1(1), 53, 1977.
201. Bélanger, M.-C. et al., Hemocompatibility, biocompatibility, inflammatory, and in vivo studies of primary reference materials low-density polyethylene and polydimethylsiloxane: a review, J. Biomed. Mater. Res. (Appl. Biomater.), 58, 467, 2001.
202. Boyden, S., The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes, J. Exp. Med., 115, 453, 1962.
203. Mason, R.G., Blood compatibility of biomaterials: evaluation of a simple screening test, Biomater. Med. Dev. Artif. Organs, 1(1), 131, 1973.
204. Mason, R.G. et al., Blood compatibility of biomaterials: further evaluation of the Lindholm test, Biomater. Med. Dev. Artif. Organs, 2(1), 21, 1974.
205. McCann, J. et al., Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals, Proc. Nat. Acad. Sci., 72(12), 5135, 1975.
206. Merritt, K., Immunological testing of biomaterials, in Techniques of Biocompatibility Testing, Vol. II, Williams, D.F. (Ed.), CRC Press, Boca Raton, FL, 1986, 123.
207. Merritt, K. and Brown, S.A., Tissue reaction and metal sensitivity, Acta Orthop. Scand., 51, 403, 1980.
208. Mital, M. and Cohen, J., Toxicity of metal particles in tissue culture. Part II: a new assay method using cell counts in the lag phase, J. Bone Joint Surg., 50A, 547, 1968.
209. Northup, S.J., Mammalian cell culture methods, in Handbook of Biomaterials Evaluation., von Recum, A.F. (Ed.), Macmillan, New York, 1986, 209.
210. Schmalz, G., Concepts in biocompatibility testing of dental restorative materials, Clin. Oral Invest., 1(4), 154, 1997.
211. Shanbhag, A.H. et al., Macrophage/particle interactions: effect of size, composition, and surface area, J. Biomed. Mater. Res., 28, 81, 1994.
212. Skarja, G.A. et al., A cone-and-plate device for the investigation of platelet biomaterial interactions, J. Biomed. Mater. Res., 34, 427, 1997.
213. Wieslander, A., Magnusson, A. and Kjellstrand, P., Use of cell culture to predict toxicity of solid materials in blood contact, Biomater. Artif. Cells Artif. Org., 18(3), 367, 1990.
214. Wilsnack, R.E., Quantitative cell culture biocompatibility testing of medical devices and correlation to animal tests, Biomater. Med. Dev. Artif. Org., 4(3-4), 235, 1976.
215. Turner, J.E. Lawrence, W.H. and Autian, J. "Subacute Toxicity Testing of Biomaterials using Histopathologic Evaluation of Rabbit Muscle Tissue, " Journal Biomedical Material Research, Vol. 7, No. 39.1973.
216. Cohen, J. "Assay of Foreign-Body Reaction." Journal of Bone and Joint Surgery, No. 41 A, 1959, pp. 152-166.
217. Ferguson Jr A.B. Laing, P. G. and Hodge, E.S." The Ionization of Metal Implants in Living Tissues, " Journal of Bone and Joint Surgery, No. 42A, 1960, pp. 77-90.
218. Laing, P.G. Ferguson. A. B., Jr., and Hodge, E. S., "Tissue Reaction in Rabbit Muscle Exposed to Metallic Implants," Journal Biomedical Materials Research, No. I, 1967, pp. 135-149.
219. Black, J., Metal on metal bearings: a practical alternative to metal on polyethylene bearings? Clin. Orthop. Rel. Res., 329S, S244, 1996.
220. Burdette, W.J. and Gehan, E.A., Planning and Analysis of Clinical Studies, Charles C Thomas, Springfield, IL, 1970.
221. Chen, E.H. and Black, J., Materials design analysis of the prosthetic anterior cruciate ligament, J. Biomed. Mater. Res., 14, 567, 1980.
222. Dobelle, W.H. et al., How to comply with the Food and Drug Administration's new "investigational device exemption (IDE)" regulations, including an application form, Artif. Organs, 4(4), 1, 1980.
223. International Standards Organization, Biological testing of medical and dental materials and devices, Part 1: guidance on selection of tests. ISO/DIS 10993-1:1994. ISO, Switzerland.
224. Kammula, R.G., Tripartite biocompatibility guidance for medical devics, in Biocompatibility Workshop Notebook, Duncan, P.E. and Wallin, R.F. (Eds.), Society for Biomaterials, San Antonio, TX, 1991.
225. Kiplinger, A., The Kiplinger Washington Letter, 68(20), 4, 1991.
226. Munson, T.E., FDA LAL guideline - update, Prog. Clin. Biol. Res., 231, 143, 1987.
227. Ross, V.C. and Twohy, C.W., Endotoxins and medical devices, Prog. Clin. Biol. Res., 189, 267, 1985.
228. Silverman, W.A., Human Experimentation: A Guided Step into the Unknown, Oxford University Press, Oxford, 1985.
229. Stark, N.J., How to organize a biocompatibility testing program: a case study, Med. Dev. Diag. Ind., 13(6), 68, 1991.
230. American Dental Association, Guide to Dental Materials and Devices, 7th ed. ADA, Chicago, 1974.
231. American Society for Testing and Materials, 2005 Annual Book of ASTM Standards, Vol. 13.01: Medical Devices and Services, ASTM International, West Conshohocken, PA, 2005.
232. Black, J., "Safe" biomaterials (editorial), J. Biomed. Mater. Res., 29, 791, 1995.
233. Brown, P. and Cook, A.G., The background, formation, and maturation of committee F-4, ASTM Standardization News, October, 10, 1982.
234. Department of Health and Human Services, Everything You Always Wanted to Know about the Medical Device Amendments...and Weren't Afraid to Ask, HHS, FDA, Rockville, MD, FDA 92-4173, 1992.
235. Kahan, J.S. and Holstein, H.M., The FDA Modernization Act of 1997: part 2, Med. Dev. Diag. Ind., 20(4), 77, 1998b.
236. Kahan, J.S. et al., The implications of the Safe Medical Devices Act of 1990, Med. Dev. Diag. Ind., 13(2), 44, 1991.
237. Kono, K., OMB A-119 revised, ASTM Stand. News, June, 1998, 19.
238. Mintz, M., The Therapeutic Nightmare, Houghton-Mifflin Co., Boston, 1965.
239. NF XIV, The National Formulary, 14th ed., American Pharmaceutical Association, Washington, D.C., 1975.
240. Sinclair, U., The Jungle, New American Library, New York, 1906.
241. USP XIX, The Pharmacopeia of the United States of America, 19th revision, The United States Pharmacopeial Convention, Inc., Washington, D.C., 1975.
242. USP 28, The Pharmacopeia of the United States of America, 28th revision, incorporating The National Formulary, 23rd revision, The United States Pharmacopeial Convention, Inc., Washington, D.C., 2005.
243. U.S. Congress, Medical Device Amendments, PL 94-295, 1976.
244. U.S. Congress, Safe Medical Devices, PL 101-629, 1990.
245. U.S. Congress, Safe Medical Devices, PL 102-300, 1992.
246. U.S. Congress, FDA Modernization Act, PL 105-15, 1997.
247. Asimow, M., Introduction to Design, Prentice Hall, Englewood Cliffs, NJ, 1962, 1.
248. Black, J., Orthopaedic Biomaterials in Research and Practice, Churchill Livingstone, New York, 1988, 303.
249. Cross, N., Engineering Design Methods: Strategies for Product Design, 3rd ed., John Wiley & Sons, Chichester, U.K., 2000.
250. Lewis, G., Selection of Engineering Materials, Prentice Hall, Englewood Cliffs, NJ, 1990, 179.
251. Love, S.F., Planning and Creating Successful Engineering Designs: Managing the Design Process, Los Angeles, Advanced Professional Development, Inc., 1986.
252. Robertson, J.T. and Hyatt, D., Concepts and issues of spine device development and regulation, in Capen, D.A. and Haye, W. (Eds.), Comprehensive Management of Spinal Trauma, St. Louis, C.V. Mosby, 1988, 414.
253. U.S. Congress, Medical Device Amendments. PL 94-295, 21 USC 301, 1976.
254. Black, J. and Fielder, J.H., Ethical aspects in device retrieval, Proc. Implant Retrieval Symposium, Society for Biomaterials, St. Charles, LA, 9/17-20/92, 14-1.
255. Jacobs, J.J. et al., Postmortem retrieval of total joint replacement components, J. Biomed. Mater. Res. (Appl. Biomat.), 48(3), 385, 1999.
256. Moss, A.J., Advance Data from Vital and Health Statistics, No. 191, National Center for Health Statistics, 1991, 1.
257. FDA 91-4246: Classification Names for Medical Devices and in Vitro Diagnostic Products. U.S. Government Printing Office, Washington, D.C., 1991.
258. Maquet, P. and Furlong, R., The Law of Bone Remodeling, Wolff, H. (1892), Springer-Verlag, Berlin, (transl.), 1986.
259. Newman Dorland, W.A., Dorland's Illustrated Medical Dictionary, 30th ed., W.B. Saunders, Philadelphia, 2003.
260. Szycher, M., Szycher's Dictionary of Biomaterials and Medical Devices, Technomic Publishing Co., Lancaster, PA, 1992.
261. Williams, D.F. (Ed.), The Williams Dictionary of Biomaterials, Liverpool University Press, Liverpool, U.K., 1999.
262. Williams, D.F. (Ed.), Definitions in Biomaterials: Proceedings of a Consensus Conference of the European Society for Biomaterials, Chester, England, March 3-5, 1986. Elsevier, Amsterdam, 1987.
263. Williams, D.F., Black, J. and Doherty, P.J., Definitions in biomaterials, Second Consensus Conference on Definitions in Biomaterials, in Doherty, P.J., Williams, R.L., Williams, D.F. and Lee, A.J.C. (Eds.), Biomaterial-Tissue Interfaces. Advances in Biomaterials Vol. 10, Elsevier, Amsterdam, 1992,